tirzepatide weight loss trial clinical results is FDA-approved for management, with trials showing average weight of 15–22.5% over 72 weeks. It's a What to Know Before Starting

Entry point for public reimbursement Using the reduced off-patent price as a strong argument for increased access, Canada could become the first market with wide-scale reimbursement of existing primary care medicines, including GLP-1s for diabetes, to designate off-patent semaglutide as the first-line anti-obesity medication (AOM)

Personalized compounded tirzepatide activates two receptors (GIP and GLP-1), which is why a lot of patients notice even greater results

Commitment to Branded Medications At Klinic, we strictly prescribe branded medications such as Wegovy and Zepbound, ensuring you receive high-quality, efficacious treatments backed by regulatory safety standards and clinical trial data

Maintain a Balanced Diet